237690.KQ
ST Pharm Co.,Ltd.
KOSDAQKRWEQUITY
DELAYED
Last price
99,700.00
▼ 11,200.00 (10.10%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
105,500.00
Prev close
110,900.00
Day high
107,300.00
Day low
97,900.00
Volume
423.73K
Market cap
$2.08T
P/E (TTM)
—
52W range
84,100.00 – 172,100.00
Day trading desk
Gap from prior close
-4.87%
Prior close 110,900.00
VWAP
101,057.02
-1.34% from price
Relative volume
2.63×
Unusually busy
Session range
9.60%
97,900.00 – 107,300.00
Position in range
19%
Near session low
ATR (14D)
7,750.00
7.77% of price
Prior day high
121,500.00
PDH
Prior day low
105,000.00
PDL
Bid / ask spread
—
Quote not published
Session volume
415.67K
Avg 157.80K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.34%
-6.0%
1M
-11.77%
-15.5%
3M
-20.11%
-23.2%
6M
-32.50%
-43.6%
YTD
-16.36%
-28.6%
1Y
+9.68%
-10.3%
3Y
+36.20%
-38.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 237690.KQ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap$2.08T
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $331.68B | $273.75B | $284.99B | $249.32B | +21.2% |
| Operating revenue | $331.68B | $273.75B | $284.99B | $249.32B | +21.2% |
| Cost of revenue | $195.48B | $177.59B | $172.88B | $160.39B | +10.1% |
| Gross profit | $136.20B | $96.16B | $112.12B | $88.93B | +41.6% |
| Research & development | $23.71B | $22.11B | $30.45B | $26.31B | +7.2% |
| Selling, general & admin | $12.60B | $11.08B | $9.78B | $9.20B | +13.8% |
| Total operating expense | $81.27B | $68.47B | $78.60B | $71.08B | +18.7% |
| Operating income | $54.93B | $27.69B | $33.51B | $17.85B | +98.4% |
| Net interest income | -$72.06M | -$3.11B | -$3.72B | -$1.63B | +97.7% |
| Pre-tax income | $58.72B | $42.75B | $23.35B | $19.24B | +37.4% |
| Tax provision | $4.16B | $10.28B | $5.83B | $1.72B | -59.5% |
| Net income | $54.99B | $34.71B | $19.58B | $18.00B | +58.4% |
| Net income to common | $54.99B | $34.71B | $19.58B | $18.00B | +58.4% |
| Basic EPS | 2,706.00 | 1,780.00 | 1,041.00 | 957.00 | +52.0% |
| Diluted EPS | 2,688.00 | 1,780.00 | 1,041.00 | 957.00 | +51.0% |
| EBIT | $62.76B | $50.49B | $29.46B | $22.10B | +24.3% |
| EBITDA | $92.64B | $76.07B | $52.49B | $39.71B | +21.8% |
| Basic shares | 20.32M | 19.50M | 18.81M | 18.81M | +4.2% |
| Diluted shares | 20.46M | 19.50M | 18.81M | 18.81M | +4.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.55B | $63.41B | $50.10B | $50.20B | — | -51.8% |
| Cash & short-term investments | $90.99B | $120.92B | $90.10B | $50.20B | — | -24.8% |
| Accounts receivable | $96.66B | $67.85B | $120.57B | $94.21B | — | +42.5% |
| Inventory | $169.47B | $126.96B | $120.74B | $107.62B | — | +33.5% |
| Total current assets | $372.67B | $330.08B | $348.38B | $263.23B | — | +12.9% |
| Property, plant & equipment | $359.33B | $338.69B | $280.11B | $257.88B | — | +6.1% |
| Goodwill & intangibles | $17.01B | $16.53B | $13.46B | $12.48B | — | +2.9% |
| Total assets | $782.57B | $721.88B | $675.44B | $570.65B | — | +8.4% |
| Total current liabilities | $164.75B | $133.28B | $83.74B | $179.22B | — | +23.6% |
| Current debt | $76.53B | $72.22B | $29.21B | $114.15B | — | +6.0% |
| Long-term debt | — | $43.26B | $159.69B | $16.71B | $91.45B | — |
| Total debt | $78.71B | $118.14B | $192.08B | $134.52B | — | -33.4% |
| Total liabilities | $189.56B | $218.88B | $288.53B | $229.55B | — | -13.4% |
| Retained earnings | $204.24B | $159.44B | $135.73B | $126.89B | — | +28.1% |
| Shareholder equity | $593.44B | $503.13B | $384.55B | $337.63B | — | +17.9% |
| Working capital | $207.92B | $196.80B | $264.63B | $84.01B | — | +5.7% |
| Net tangible assets | $576.44B | $486.60B | $371.09B | $325.15B | — | +18.5% |
| Shares issued | 20.84M | 20.15M | 18.81M | 18.81M | — | +3.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $54.56B | $32.46B | $17.52B | $17.52B | +68.1% |
| Depreciation & amortisation | $29.88B | $25.58B | $23.03B | $17.60B | +16.8% |
| Stock-based compensation | $1.54B | $3.25B | $5.30B | $5.02B | -52.5% |
| Change in working capital | -$79.38B | $36.70B | -$64.78B | -$40.82B | -316.3% |
| Operating cash flow | $13.99B | $109.45B | $1.30B | $7.03B | -87.2% |
| Capital expenditure | -$47.29B | -$83.22B | -$43.44B | -$60.66B | +43.2% |
| Investing cash flow | -$26.33B | -$86.54B | -$82.39B | -$5.72B | +69.6% |
| Dividends paid | -$10.08B | -$9.40B | -$9.40B | -$9.40B | -7.1% |
| Financing cash flow | -$20.08B | -$10.95B | $81.40B | $10.81B | -83.3% |
| Free cash flow | -$33.30B | $26.23B | -$42.14B | -$53.63B | -227.0% |
| End cash position | $30.55B | $63.41B | $50.10B | $50.20B | -51.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $66.96B | $129.10B | $81.91B | $68.25B | $52.42B | -48.1% |
| Operating revenue | $66.96B | $129.10B | $81.91B | $68.25B | $52.42B | -48.1% |
| Cost of revenue | $35.84B | $81.16B | $44.92B | $36.24B | $33.15B | -55.8% |
| Gross profit | $31.12B | $47.94B | $36.99B | $32.01B | $19.27B | -35.1% |
| Research & development | $6.51B | $5.41B | $6.68B | $6.11B | $5.51B | +20.2% |
| Selling, general & admin | $3.39B | $3.58B | $2.90B | $3.53B | $2.59B | -5.3% |
| Total operating expense | $19.60B | $21.68B | $22.26B | $19.09B | $18.24B | -9.6% |
| Operating income | $11.53B | $26.26B | $14.72B | $12.92B | $1.03B | -56.1% |
| Net interest income | $5.65B | -$1.21B | $6.13B | -$5.53B | $527.86M | +568.9% |
| Pre-tax income | $17.67B | $29.28B | $20.98B | $6.91B | $1.56B | -39.7% |
| Tax provision | $2.47B | -$1.75B | $3.52B | $1.54B | $851.41M | +241.1% |
| Net income | $15.06B | $30.95B | $17.57B | $5.42B | $1.04B | -51.3% |
| Net income to common | $15.06B | $30.95B | $17.57B | $5.42B | $1.04B | -51.3% |
| Basic EPS | 725.00 | — | 849.00 | 269.00 | 52.00 | — |
| Diluted EPS | 723.00 | — | 849.00 | 269.00 | 52.00 | — |
| EBIT | $11.53B | $34.09B | $14.72B | $12.92B | $1.03B | -66.2% |
| EBITDA | $20.05B | $42.40B | $23.11B | $19.52B | $7.61B | -52.7% |
| Basic shares | 20.78M | — | 20.70M | 20.15M | 20.07M | — |
| Diluted shares | 20.83M | — | 20.70M | 20.15M | 20.07M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $111.27B | $30.55B | $44.28B | $41.72B | $24.77B | — | +264.3% |
| Cash & short-term investments | $199.09B | $90.99B | $119.38B | $89.13B | $119.17B | — | +118.8% |
| Accounts receivable | $37.52B | $96.66B | $49.24B | $57.51B | $56.61B | — | -61.2% |
| Inventory | $194.52B | $169.47B | $174.63B | $163.13B | $146.64B | — | +14.8% |
| Total current assets | $445.21B | $372.67B | $356.74B | $322.49B | $336.73B | — | +19.5% |
| Property, plant & equipment | $358.99B | $359.33B | $362.28B | $361.26B | $354.44B | — | -0.1% |
| Goodwill & intangibles | $17.28B | $17.01B | $16.76B | $16.70B | $16.70B | — | +1.6% |
| Total assets | $849.94B | $782.57B | $755.49B | $732.39B | $742.16B | — | +8.6% |
| Total current liabilities | $214.42B | $164.75B | $174.97B | $147.60B | $162.14B | — | +30.2% |
| Current debt | $72.02B | $76.53B | $77.28B | $69.67B | $70.42B | — | -5.9% |
| Long-term debt | — | — | — | $45.50B | $44.36B | $43.26B | — |
| Total debt | $74.33B | $78.71B | $80.00B | $118.30B | $118.26B | — | -5.6% |
| Total liabilities | $238.69B | $189.56B | $199.52B | $231.94B | $247.87B | — | +25.9% |
| Retained earnings | $208.77B | $204.24B | $173.57B | $155.99B | $150.39B | — | +2.2% |
| Shareholder equity | $611.60B | $593.44B | $556.62B | $501.01B | $494.71B | — | +3.1% |
| Working capital | $230.78B | $207.92B | $181.76B | $174.89B | $174.59B | — | +11.0% |
| Net tangible assets | $594.32B | $576.44B | $539.86B | $484.31B | $478.00B | — | +3.1% |
| Shares issued | 20.84M | 20.84M | 20.70M | 20.15M | 20.15M | — | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $15.20B | $31.02B | $17.46B | $5.37B | $708.72M | — | -51.0% |
| Depreciation & amortisation | $8.53B | $8.31B | $8.39B | $6.60B | $6.58B | — | +2.6% |
| Stock-based compensation | $928.19M | $475.99M | $245.09M | $192.75M | $627.75M | — | +95.0% |
| Change in working capital | $74.17B | -$66.97B | $5.06B | -$27.45B | $9.98B | — | +210.8% |
| Operating cash flow | $103.09B | -$21.16B | $29.25B | -$11.45B | $17.36B | — | +587.1% |
| Capital expenditure | -$8.99B | -$5.89B | -$14.61B | -$5.98B | -$20.81B | — | -52.7% |
| Investing cash flow | -$27.32B | $11.58B | -$25.16B | $41.22B | -$53.96B | — | -336.0% |
| Dividends paid | — | $0 | $0 | — | — | $0 | — |
| Financing cash flow | $4.03B | -$2.89B | -$3.14B | -$11.50B | -$2.55B | — | +239.6% |
| Free cash flow | $94.10B | -$27.05B | $14.64B | -$17.43B | -$3.45B | — | +447.9% |
| End cash position | $111.27B | $30.55B | $44.28B | $41.72B | $24.77B | — | +264.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $97.50B | +19.1% |
| Next quarter | — | — | $149.38B | +15.8% |
| Current year | 3,325.72 | 9 | $419.97B | +26.7% |
| Next year | 4,360.20 | 10 | $504.81B | +20.2% |
Analyst targets & ownership
Mean target$180,000.00
High target$210,000.00
Low target$140,000.00
Implied upside80.54%
Analyst count10
ConsensusNONE
Strong buy / Buy4 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
104,730.00
-4.80% from price
SMA 20
101,170.00
-1.45% from price
SMA 50
114,578.00
-12.99% from price
SMA 100
127,600.00
-21.87% from price
SMA 200
128,934.50
-22.67% from price
EMA 12
103,754.40
-3.91% from price
EMA 26
106,704.21
-6.56% from price
EMA 50
113,154.31
-11.89% from price
RSI (14)
43.8
Neutral
MACD (12,26,9)
-2,949.82
Hist 1,070.28
ATR (14)
7,750.00
7.77% of price
Realised vol 30D
87.8%
Annualised
Bollinger upper
116,255.50
20, 2σ
Bollinger lower
86,084.50
20, 2σ
50 / 200 cross
Death
114,578.00 vs 128,934.50
Trend bias
Below 200
-22.67%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.17
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
87.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-49.8%
Peak to trough
Max drawdown 5Y
-58.2%
Peak to trough
ATR 14
7,750.00
7.77% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Kane voted German footballer of the year
AFP · 10m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 12m ago
Is GE Vernova Under $1,000 a Bargain or a Trap? Here's the Honest Answer.
Motley Fool · 13m ago
The Idiot’s Guide to Stocks
24/7 Wall St. · 16m ago
Exclusive: Anthropic's $2 Trillion Valuation Faces a Reality Check—SPCX Offers a Warning, Wall Street Veteran Says
Benzinga Private Markets · 16m ago
Trump made a multimillion-dollar bond bet — and Fed Chair Kevin Warsh could shape the outcome. What investors can learn
Moneywise · 16m ago
DREAMO and DREAMOSIS Bring the Collectible Character Into a New Physical-Digital World
PR Newswire · 16m ago
Bio Ionic Partners with Ulta Beauty on Limited Edition Jade Dream Collection
PR Newswire · 16m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.